medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2006, Number 11

<< Back Next >>

Ginecol Obstet Mex 2006; 74 (11)

Epidemiology of breast cancer

Rodríguez CSA, Capurso GM

Language: Spanish
References: 31
Page: 585-593
PDF size: 427.76 Kb.


ABSTRACT

Breast cancer is the most frequent malignant tumor worldwide. In recent years there has been observed an increase in its frequency, especially in developing countries, as Mexico, where mortality is arriving to the first cause of death in females. This is, in part, due to a delayed diagnosis, most frequently done in locally advances stages with a low cure rate. This is a review of all risk factors: age, sex, personal and familial history, genetic syndromes, associated breast disease, geographic distribution, body structure and environmental, hormonal, reproductive and dietary factors. It is concluded that breast cancer is a public health problem in developed and developing countries, and the best methods to drop mortality for breast cancer is the wide use of screening mammography in women at risk, in order to find cancers at initial stages and offer the adequate treatment.


REFERENCES

  1. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002. Cancer incidence, mortality and prevalence worldwide. International Agency for Research on Cancer. World Health Organization. Lyon: IARC Press, 2002.

  2. Mettlin C. Global breast cancer mortality statistics. CA Cancer J Clin 1999;49:138-44.

  3. Compendio del registro histopatológico de neoplasias en México. Morbilidad y mortalidad. México: Secretaría de Salud, 1999.

  4. Rodríguez-Cuevas SA, Labastida SA, Tapia R, Kuri P, Macías C. Registro histopatológico de neoplasias en México. Población derechohabiente del IMSS 1991-1996. México: Ciencia y Cultura Latinoamericana, 1999;p:56.

  5. Ries LAG, Kosary CL, Hankey BF, Miller BA, Edwards BK, editors. SEER Cancer Statistics Review, 1973-1995. Bethesda: National Cancer Institute, 1998.

  6. Chu KC, Tarone R, Kessler L, et al. Recent trends in US breast cancer incidence, survival and mortality rates. J Natl Cancer Inst 1996;88:1571-9.

  7. La Vecchia C, Negri E, Levi F, Decarli A. Age, cohort of birth, and period of death trends in breast cancer mortality in Europe. J Natl Cancer Inst 1997;89:732-4.

  8. Jemal A, Murray T, Samuels A, et al. Cancer Statistics 2003. CA Cancer J Clin 2003;53:5-26.

  9. Rodríguez-Cuevas S, Macías CG, Franceschi D, Labastida S. Breast carcinoma presents a decade earlier in Mexican women than in women in the United Status or European countries. Cancer 2001;91:863-8.

  10. Hoskins KF, Stopfer JE, Calzone KA, et al. Assesment and counseling for women with a family history of breast cancer. A guide to clinicians. JAMA 1995;273:577-85.

  11. Futreal P, Liu Q, Shattuck-Gidens D, et al. BRCA 1 mutation in breast an ovary carcinomas. Science 1994;226:120-2.

  12. Wooster R, Neuhausen S, Mangion J, et al. Localization of a breast cancer susceptibility gene, BRCA 2, to chromosome 13q12-13. Science 1994;265:2088-90.

  13. Rivera-Claise E, Rodríguez-Cuevas SA, Luna Pérez P. Epidemiología y aspectos genéticos del cáncer de mama. Cir Gral 1997;19:180-6.

  14. Dupont DW, Page DL. Breast cancer risk associated with proliferative disease, age at first birth and a family history of breast cancer. Am J Epidemiol 1987;125:769-79.

  15. Shaaban AM, Sloane JP, West CR, et al. Histopathological types of benign breast lesions and the risk of breast cancer. A case-control study. Am J Surg Pathol 2002;26:421-30.

  16. Blot WJ, McLaughlin JK. Geographic patterns of breast cancer among American women (editorial). J Natl Cancer Inst 1995:87:1819-20.

  17. Peña-Gómez RM. Edad de la menarquia en tres grupos de niñas mexicanas. Departamento de Investigaciones antropológicas. INAH. Publicación 24. México: Secretaría de Educación Pública, 1970.

  18. Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev 1993;15:36-47.

  19. Brinton LA, Daling JR, Liff JM, et al. Oral contraceptives and breast cancer risk among younger women. J Natl Cancer Inst 1995;87:827-35.

  20. Singletary SE. Rating the risk factors for breast cancer. Ann Surg 2003;237:474-82.

  21. Rossouw JE, Anderson GL, Prentice RL, et al. Writing group for the Women’s Health Initiative Investigators: Risks and benefits of estrogen plus progestins in menopausal women. Principal results from the Women’s Health Initiative randomized controlled trial. JAMA 2002;288:321-33.

  22. Barclay L. More evidence linking estrogen plus progestin therapy to breast cancer. JAMA 2003;289:3243-53,3254-63,3304-6.

  23. Wynder EL, Cohen LA, Muscat JE, et al. Breast cancer: Weighing the evidence for a promoting role of dietary fat. J Natl Cancer Inst 1997;89:766-75.

  24. Greenwald P, Sherwood K, McDonald SS. Fat, caloric intake and obesity: Lifestyle risk factors for breast cancer. J Am Diet Assoc 1997;97(suppl):524-30.

  25. Vogel VG, Bevers T. Handbook of breast cancer risk-assessment. Evidence-based guidelines for evaluation, prevention, counseling and treatment. Massachusets: Jones & Bartlett Publishers, 2003. ISBN 0-7637-1860-2.

  26. World Health Organization Databank.

  27. Tominaga S, Kuroishi T, Aoki K. Cancer mortality statistics in 33 countries. Geneva: International Union Against Cancer, 1998.

  28. Nagata C, Kawakami N, Shimizu H. Trends in the incidence rate and risk factors for breast cancer in Japan. Breast Cancer Res Treat 1997;44:75-82.

  29. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989;81:1879-86.

  30. National Cancer Institute. Cancer new web site, available at: www.cancernet.nci,nih.gov

  31. Bland KI, Menck HR, Scott-Conner CE, et al. The National Cancer Database. 10 year survey of breast cancer treatment at hospitals in the United States. Cancer 1998;83:1262-73.




2020     |     www.medigraphic.com